Oral ketamine vs placebo in patients with cancer-related neuropathic pain
Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropat...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Medical Association
2018
|
| Online Access: | https://eprints.nottingham.ac.uk/51161/ |